• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Discontinuation of both cangrelor and ticagrelor because of severe dyspnea during primary angioplasty.

作者信息

Di Filippo Chiara, Caniato Flavia, Cappelli Francesco, Mattesini Alessio, Meucci Francesco, Sori Andrea, Stolcova Mira, Agostini Cecilia, Bernardo Pasquale, Di Mario Carlo

机构信息

Heart Lung and Vessels Department, Structural Interventional Cardiology, Careggi University Hospital, Florence, Italy.

出版信息

J Cardiovasc Med (Hagerstown). 2021 Apr 1;22(4):317-319. doi: 10.2459/JCM.0000000000001042.

DOI:10.2459/JCM.0000000000001042
PMID:33633048
Abstract
摘要

相似文献

1
Discontinuation of both cangrelor and ticagrelor because of severe dyspnea during primary angioplasty.在初次血管成形术期间，因严重呼吸困难停用坎格雷洛和替格瑞洛。
J Cardiovasc Med (Hagerstown). 2021 Apr 1;22(4):317-319. doi: 10.2459/JCM.0000000000001042.
2
Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.在接受直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者中，用坎格瑞洛和替卡格雷洛进行血小板抑制。
Circulation. 2019 Apr 2;139(14):1661-1670. doi: 10.1161/CIRCULATIONAHA.118.038317.
3
Intracoronary cangrelor administration-assisted primary percutaneous coronary intervention in a patient with essential thrombocythemia and recurrent ST-segment elevation myocardial infarction.冠状动脉内给予坎格雷洛辅助原发性经皮冠状动脉介入治疗一名原发性血小板增多症合并复发性ST段抬高型心肌梗死患者。
J Cardiovasc Med (Hagerstown). 2020 Oct;21(10):825-828. doi: 10.2459/JCM.0000000000001006.
4
de Winter syndrome or inferior STEMI?德温特综合征还是下壁 ST 段抬高型心肌梗死？
BMC Cardiovasc Disord. 2021 Dec 28;21(1):614. doi: 10.1186/s12872-021-02441-4.
5
Randomized Comparison of Oral P2Y-Receptor Inhibitor Loading Strategies for Transitioning From Cangrelor: The ExcelsiorLOAD2 Trial.从坎格雷洛转换时口服 P2Y 受体抑制剂加载策略的随机比较：ExcelsiorLOAD2 试验。
JACC Cardiovasc Interv. 2017 Jan 23;10(2):121-129. doi: 10.1016/j.jcin.2016.10.004.
6
Clinical use of cangrelor: nationwide experience from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).坎格雷洛的临床应用：来自瑞典冠状动脉造影和血管成形术登记处（SCAAR）的全国性经验。
Eur Heart J Cardiovasc Pharmacother. 2019 Jul 1;5(3):151-157. doi: 10.1093/ehjcvp/pvz002.
7
Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial.替格瑞洛、替罗非班和嚼碎或标准普拉格雷方案在 ST 段抬高型心肌梗死患者中的应用：FABOLUS-FASTER 试验的主要结果。
Circulation. 2020 Aug 4;142(5):441-454. doi: 10.1161/CIRCULATIONAHA.120.046928. Epub 2020 Jun 27.
8
Cangrelor in Percutaneous Coronary Intervention: Current Status and Perspectives.坎格雷洛在经皮冠状动脉介入治疗中的现状与展望
J Cardiovasc Pharmacol Ther. 2018 Jan;23(1):13-22. doi: 10.1177/1074248417715004. Epub 2017 Jun 15.
9
Optimal platelet inhibition with cangrelor in comatose survivors of out-of-hospital cardiac arrest undergoing primary percutaneous coronary intervention.在接受直接经皮冠状动脉介入治疗的院外心脏骤停昏迷幸存者中，坎格雷洛实现最佳血小板抑制作用。
Resuscitation. 2018 Sep;130:e1-e2. doi: 10.1016/j.resuscitation.2018.06.032. Epub 2018 Jun 30.
10
Prasugrel or Ticagrelor in ST-Segment-Elevation Myocardial Infarction Patients With Diabetes Mellitus.普拉格雷或替卡格雷用于患有糖尿病的ST段抬高型心肌梗死患者
Circulation. 2017 Aug 8;136(6):602-604. doi: 10.1161/CIRCULATIONAHA.117.028745.

引用本文的文献

1
Adenosine in Interventional Cardiology: Physiopathologic and Pharmacologic Effects in Coronary Artery Disease.腺苷在介入心脏病学中的应用：冠心病的病理生理和药理作用。
Int J Mol Sci. 2024 May 28;25(11):5852. doi: 10.3390/ijms25115852.